Standout Papers
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma (2011)
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial (2012)
Immediate Impact
4 by Nobel laureates 19 from Science/Nature 62 standout
Citing Papers
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Colorectal cancer
2024 Standout
Works of Roger von Moos being referenced
Encorafenib (Lgx818), an Oral Braf Inhibitor, in Patients (Pts) with Braf V600E Metastatic Colorectal Cancer (Mcrc): Results of Dose Expansion in an Open-Label, Phase 1 Study
2014
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
2012 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Roger von Moos | 4079 | 1835 | 1121 | 1348 | 232 | 6.0k | |
| Aristotelis Bamias | 2984 | 2184 | 1875 | 1600 | 274 | 6.7k | |
| Shunji Takahashi | 5147 | 2319 | 878 | 1276 | 350 | 7.6k | |
| Rossana Berardi | 4061 | 2725 | 1094 | 1836 | 342 | 7.1k | |
| Penella J. Woll | 4879 | 2956 | 822 | 1856 | 166 | 7.7k | |
| Gary Richardson | 2574 | 1212 | 464 | 723 | 103 | 3.7k | |
| Luís Costa | 3824 | 1507 | 907 | 1432 | 179 | 5.5k | |
| Sandy Srinivas | 2871 | 3340 | 2113 | 1929 | 191 | 6.3k | |
| Guenther G. Steger | 4434 | 1433 | 593 | 1260 | 155 | 5.8k | |
| G.H. Blijham | 2314 | 1166 | 1034 | 1044 | 88 | 4.6k | |
| Judith R. Kroep | 3003 | 1770 | 678 | 1549 | 213 | 6.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...